Meanwhile, the BSE Sensex was up 88.81 points, or 0.51%, to 17,471.99.
On BSE, 16,008 shares were traded in the counter as against an average daily volume of 1.19 lakh shares in the past one quarter.
The stock hit a high of Rs 33.80 and a low of Rs 31.15 so far during the day. The stock had hit a 52-week high of Rs 61 on 18 January 2010 and a 52-week low of Rs 20.35 on 16 March 2009.
The stock had outperformed the market over the past one month till 15 March 2010, gaining 13.82% compared with the Sensex's 7.02% rise. It outperformed the market in past one quarter, soaring 32.19% as against 1.71% rise in the Sensex.
The small-cap pharmaceutical company has an equity capital of Rs 5 crore. Face value per share is Rs 10.
The current price of Rs 31.55 discounts the company's Q3 December 2009 annualised EPS of Rs 2.16, by a PE multiple of 14.60.
Aarey Drugs & Pharmaceuticals' net profit fell 15.6% to Rs 0.27 crore on a 46% rise in sales to Rs 12.10 crore in Q3 December 2009 over Q3 December 2008.
Aarey Drugs & Pharmaceuticals manufactures and sells active pharmaceutical ingredients/bulk drugs in India.